REGISTERED NUMBER: 11905256 (England and Wales)

A2 HEALTH LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

J T Vadodaria

REGISTERED OFFICE:

Swillington Pharmacy Church Lane

Swillington

Leeds

LS26 8DY

REGISTERED NUMBER:

11905256 (England and Wales)

ACCOUNTANTS:

SMH Sheards

Vernon House

40 New North Road

Huddersfield

West Yorkshire

HD1 5LS

FIXED ASSETS

Intangible assets

4

1,019,403

1,019,403

Tangible assets

5

342,530

237,014

1,361,933

1,256,417

CURRENT ASSETS

Stocks

45,347

82,129

Debtors

6

278,496

258,231

Cash at bank and in hand

79,466

63,942

403,309

404,302

CREDITORS

Amounts falling due within one year

7

(277,356

)

(304,426

)

NET CURRENT ASSETS

125,953

99,876

TOTAL ASSETS LESS CURRENT LIABILITIES

1,487,886

1,356,293

CREDITORS

Amounts falling due after more than one year

8

(1,048,222

)

(1,039,859

)

PROVISIONS FOR LIABILITIES

11

(30,799

)

(3,253

)

NET ASSETS

408,865

313,181

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

408,765

313,081

SHAREHOLDERS' FUNDS

408,865

313,181

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 December 2025 and were signed by:

J T Vadodaria - Director

1.	STATUTORY INFORMATION

A2 Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the sale of goods is recognised when the significant risk and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Goodwill

Goodwill is considered to have an indefinite life that can be demonstrated, and the value of the goodwill can be readily measured. The dispensing chemist industry, in which the company operates, has high market entry

barriers due to the nature of licence agreements with local health authorities and the limited number available in the marketplace. The value of the business can be ascertained by reference to the current value of goodwill which is payable in the market based on a price per £ in relation to the levels of turnover for each individual pharmacy. The director reviews the value of goodwill on an annual basis and considers it to be worth in excess of the net book value.

This is a departure from Companies Act 2006 which states that goodwill must be amortised, but the director has departed from these requirements for the purpose of showing a true and fair view.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Land and buildings

-

2% on cost

Plant and machinery etc

-

33% on cost, 25% on cost and 10% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Basic financial assets, which include trade and other debtors, amounts owed by group undertakings and cash and bank balances, are initially measured at transaction price including transaction costs.

Financial assets, other than those held at fair value through profit or loss, are assessed for indicators of impairment at each balance sheet date, with any impairment losses being recognised in profit or loss. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed in profit or loss.

Financial liabilities are classified depending on the substance of the contractual arrangements entered into.

Basic financial liabilities, including trade and other creditors, bank loans, finance leases, accruals and amounts owed to group undertakings, are initially recognised at transaction price.

Debt instruments are subsequently measured at amortised cost using the effective interest method.

Financial assets and liabilities are derecognised when the company's contractual obligations are settled, cancelled or they expire.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Grants

Grant income is accounted for on an accruals basis, with the income matching the year in which the related expenditure is incurred.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2024 - 12 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

1,059,196

AMORTISATION

At 1 April 2024

and 31 March 2025

39,793

NET BOOK VALUE

At 31 March 2025

1,019,403

At 31 March 2024

1,019,403

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2024

233,335

20,827

254,162

Additions

-

131,995

131,995

At 31 March 2025

233,335

152,822

386,157

DEPRECIATION

At 1 April 2024

9,333

7,815

17,148

Charge for year

4,667

21,812

26,479

At 31 March 2025

14,000

29,627

43,627

NET BOOK VALUE

At 31 March 2025

219,335

123,195

342,530

At 31 March 2024

224,002

13,012

237,014

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and

machinery

etc

£

COST

Additions

120,639

At 31 March 2025

120,639

DEPRECIATION

Charge for year

16,282

At 31 March 2025

16,282

NET BOOK VALUE

At 31 March 2025

104,357

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

134,689

148,055

Amounts owed by associates

104,358

88,232

Other debtors

39,449

21,944

278,496

258,231

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

53,346

38,405

Hire purchase contracts (see note 9)

25,463

-

Trade creditors

168,731

157,147

Taxation and social security

18,851

59,750

Other creditors

10,965

49,124

277,356

304,426

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

925,008

967,394

Hire purchase contracts (see note 9)

86,290

-

Other creditors

36,924

72,465

1,048,222

1,039,859

2025

2024

£

£

Amounts falling due in more than five years:

Repayable by instalments

Bank loans

730,055

782,411

9.	LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase

contracts

2025

2024

£

£

Net obligations repayable:

Within one year

25,463

-

Between one and five years

86,290

-

111,753

-

Non-cancellable

operating leases

2025

2024

£

£

Between one and five years

45,988

64,757

In more than five years

400,000

-

445,988

64,757

10.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

Bank loans

978,354

1,005,799

The bank loan to acquire the business and property is secured over the property and by way of fixed and floating charge of the assets of the business, combined with an insurance policy over the life of the director.

Government backed loans are secured by way of government initiative.

11.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

30,799

3,253

Deferred

tax

£

Balance at 1 April 2024

3,253

Provided during year

27,546

Balance at 31 March 2025

30,799

12.	RELATED PARTY DISCLOSURES

At the year end, £36,924 (2024: £74,516) was owed to some of the shareholders directly, or through a company in which a shareholder is also a shareholder.

Interest is being paid on the loans at commercial rate of interest.

At the year end, £104,358 (2024: £88,232 was owed to the company by companies that are under common control the shareholders.